Reversible choreoathetosis after the administration of ceftriaxone sodium in patients with end-stage renal disease.
Neurologic manifestations, such as myoclonus, asterixis, seizures and altered level of consciousness, may be induced in patients with impaired renal function receiving β-lactam antibiotics, which stem in part from drug accumulation because of altered pharmacokinetics. Because of its long half-life and easy penetration into the cerebrospinal fluid, the third generation cephalosporin, ceftriaxone (CTRX), is often chosen to treat patients with end-stage renal disease (ESRD). Here, the authors describe 4 patients with ESRD complicated with bacterial infection and choreoathetosis after the administration of CTRX. Choreoathetosis disappeared without leaving sequelae after CTRX therapy was withdrawn, although the severity and symptom duration varied. To our knowledge, there are few reports on choreoathetosis associated with β-lactam antibiotic administration in patients with kidney diseases. To prevent delayed diagnosis, one should bear in mind that choreoathetosis might occur in patients with ESRD treated with CTRX, when it is given in high or even regular doses.
Sato
Yoshinori
Y
Division of Nephrology, Showa University Fujigaoka Hospital, Yokohama, Japan.
Morita
Hiroyuki
H
Wakasugi
Harue
H
Iijima
Shoji
S
Kawashima
Eri
E
Wakayama
Yoshihiro
Y
Yoshimura
Ashio
A
D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001264:Athetosis / Q000139:chemically induced*; D002443:Ceftriaxone / Q000009:adverse effects*; D002819:Chorea / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D008297:Male
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone